With our Pharmacoscopy® platform, we generate actionable insights into the functional activity of drugs and drug candidates directly in viable, primary tissue samples of human cancer patients at the single cell level.

Leverage Pharmacoscopy® to enhance the patient relevance of drug discovery and preclinical research across all R&D phases to ultimately increase the chances of success in clinical development.

Learn how Pharmacoscopy® can be used to improve patient response through ex vivo drug screening in primary tumour tissues. Explore big data applications that can drive genetic biomarker and target discovery in oncology.